Silgan Holdings (NASDAQ: SLGN) reported Q3 EPS of $0.66, $0.03 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.29 billion.

Outlook for 2017

The Company narrowed its estimate of adjusted net income per diluted share for the full year of 2017, which excludes transaction related costs attributed to announced acquisitions, rationalization charges and loss from early extinguishment of debt, to a range of $1.62 to $1.67 from a range of $1.60 to $1.70. This estimate compares to adjusted net income per diluted share for the full year of 2016 of $1.38.

The Company is providing an estimate of adjusted net income per diluted share for the fourth quarter of 2017, which excludes transaction related costs attributed to announced acquisitions and rationalization charges, in the range of $0.30 to $0.35. This estimate compares to adjusted net income per diluted share of $0.24 in the fourth quarter of 2016.

• Net income per share increased 14 percent to $0.65
• Adjusted net income per share increased 8.2 percent to $0.66
• Integration of Dispensing Systems continues successfully

GUIDANCE:

Silgan Holdings sees Q4 2017 EPS of $1.62-$1.67, versus the consensus of $1.65.

For earnings history and earnings-related data on Silgan Holdings (SLGN) click here.